Seasonal malaria chemoprevention (SMC) is effective in preventing malaria in children, particularly in areas where transmission is seasonal. Due to concerns about sulfadoxine-pyrimethamine (SP) resistance in East and southern Africa (ESA), SMC has primarily been implemented in the Sahel region of West and Central Africa. However, there is growing evidence that suggests SMC with SP and amodiaquine (AQ) retains a high level of effectiveness in ESA. This study assesses the effectiveness of SMC when delivered under programmatic conditions with unknown antimalarial drug resistance in Northern Bahr el Ghazal, South Sudan.
This poster was presented at the 72nd annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: South SudanKeywords: ASTMH | Data-informed decision-making | Health system strengthening | Research | Malaria | SMC
« Back to Publications